233 related articles for article (PubMed ID: 10951159)
21. The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis.
Xiong YQ; Tan J; Liu YM; He Q; Li L; Zou K; Sun X
J Clin Virol; 2019 May; 114():12-20. PubMed ID: 30897374
[TBL] [Abstract][Full Text] [Related]
22. Postnatal IVIG treatment for persistent anaemia in neonate due to congenital parvovirus infection.
Janssen O; Lin J
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431449
[TBL] [Abstract][Full Text] [Related]
23. Late onset of hydrops fetalis following intrauterine parvovirus B19 infection.
Mielke G; Enders G
Fetal Diagn Ther; 1997; 12(1):40-2. PubMed ID: 9101221
[TBL] [Abstract][Full Text] [Related]
24. High rate of severe fetal outcomes associated with maternal parvovirus b19 infection in pregnancy.
Beigi RH; Wiesenfeld HC; Landers DV; Simhan HN
Infect Dis Obstet Gynecol; 2008; 2008():524601. PubMed ID: 18464909
[TBL] [Abstract][Full Text] [Related]
25. Fetal parvovirus B19 infection in a twin pregnancy with 1 twin presenting with hydrops fetalis and the other asymptomatic: a case report.
Leung TN; Leung TY; Chan PK; Fung TY; Lau TK
J Reprod Med; 2007 May; 52(5):419-21. PubMed ID: 17583243
[TBL] [Abstract][Full Text] [Related]
26. [Parvovirus B19 infection in pregnancy: a cause of non-immune hydrops fetalis].
van Gessel PH; Wildschut HI; Cohen-Overbeek TE; Vermeij-Keers C
Ned Tijdschr Geneeskd; 1999 Jan; 143(1):3-7. PubMed ID: 10086088
[TBL] [Abstract][Full Text] [Related]
27. Resolution of human parvovirus B19-induced nonimmune hydrops after intrauterine transfusion.
Odibo AO; Campbell WA; Feldman D; Ling PY; Leo MV; Borgida AF; Rodis JF
J Ultrasound Med; 1998 Sep; 17(9):547-50. PubMed ID: 9733171
[TBL] [Abstract][Full Text] [Related]
28. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
29. Congenital hypoplasia of the abdominal wall muscles following fetal ascites due to parvovirus B19 infection.
Macé G; Audry G; Cortey A; Nguyen A; Slaim L; Castaigne V; Garel C; Carbonne B
Ultrasound Obstet Gynecol; 2011 Apr; 37(4):497-8. PubMed ID: 21433169
[No Abstract] [Full Text] [Related]
30. [PCR value in the diagnosis of feto-placental human parvovirus B19 hydrops fetalis: apropos of 10 cases].
Wattré P; Thirion V; Bellagra N; Subtil D; Andreoletti L; Hober D; Lion G; Dewilde A
Ann Biol Clin (Paris); 1997; 55(4):327-31. PubMed ID: 9309232
[TBL] [Abstract][Full Text] [Related]
31. Fetal brain infection with human parvovirus B19.
Isumi H; Nunoue T; Nishida A; Takashima S
Pediatr Neurol; 1999 Sep; 21(3):661-3. PubMed ID: 10513695
[TBL] [Abstract][Full Text] [Related]
32. Parvovirus b19 infection in fetal deaths.
Riipinen A; Väisänen E; Nuutila M; Sallmen M; Karikoski R; Lindbohm ML; Hedman K; Taskinen H; Söderlund-Venermo M
Clin Infect Dis; 2008 Dec; 47(12):1519-25. PubMed ID: 18991512
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection.
Nagel HT; de Haan TR; Vandenbussche FP; Oepkes D; Walther FJ
Obstet Gynecol; 2007 Jan; 109(1):42-7. PubMed ID: 17197586
[TBL] [Abstract][Full Text] [Related]
34. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin.
Matsuda H; Sakaguchi K; Shibasaki T; Takahashi H; Kawakami Y; Furuya K
J Perinat Med; 2005; 33(6):561-3. PubMed ID: 16318623
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
Elnifro E; Nisha AK; Almabsoot M; Daeki A; Mujber N; Muscat J
J Infect Dev Ctries; 2009 Apr; 3(3):218-20. PubMed ID: 19759477
[TBL] [Abstract][Full Text] [Related]
36. Human parvovirus B19 in pregnancy.
Brennand JE; Cameron AD
Hosp Med; 2000 Feb; 61(2):93-6. PubMed ID: 10748785
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
[TBL] [Abstract][Full Text] [Related]
38. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
[TBL] [Abstract][Full Text] [Related]
39. Nonimmune hydrops fetalis caused by intrauterine human parvovirus B19 infection: a case of spontaneous reversal in utero.
Faure JM; Giacalone PL; Deschamps F; Boulot P
Fetal Diagn Ther; 1997; 12(2):66-7. PubMed ID: 9218942
[TBL] [Abstract][Full Text] [Related]
40. Prenatal diagnosis of obstructive hydrocephalus associated with parvovirus B19 infection.
Zajicek M; Gindes L; Hoffmann C; Morag I; Achiron R
Obstet Gynecol; 2010 Aug; 116 Suppl 2():521-522. PubMed ID: 20664440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
